Share Price, page-3847

I think so, to double from here is not unreasonable expectation considering we already touched $9.08 or something month or so back and the magnitude of value that this upcoming news brings for Neu's future.

Positive phase 3 trial results were a great milestone no doubt, however as we have all experiencing here is that we are not fully de risked until FDA approve and the asset becomes commercial $$$$$$$$$$$$$$$$$$$$$$$

By far the biggest Ann for Neu, we know the result for the share price if we are unsuccessful with FDA approval, it should be of equal significance however in our favour should we be approved in my view.